Humana Inc. (NYSE:HUM) Given Consensus Rating of “Hold” by Brokerages

Shares of Humana Inc. (NYSE:HUM) have been given a consensus recommendation of “Hold” by the twenty-six analysts that are covering the firm, MarketBeat reports. Three equities research analysts have rated the stock with a sell rating, sixteen have given a hold rating and seven have given a buy rating to the company. The average 12 month target price among brokers that have covered the stock in the last year is $249.9130.

Several analysts have issued reports on the stock. Evercore upped their price target on shares of Humana from $195.00 to $250.00 in a report on Thursday, April 30th. UBS Group upped their price objective on shares of Humana from $195.00 to $262.00 and gave the company a “neutral” rating in a research note on Thursday, April 30th. Oppenheimer reissued an “outperform” rating and set a $260.00 price objective on shares of Humana in a research note on Thursday, April 30th. Jefferies Financial Group upped their price objective on shares of Humana from $235.00 to $290.00 in a research note on Thursday, April 30th. Finally, Guggenheim upped their price objective on shares of Humana from $252.00 to $269.00 and gave the company a “buy” rating in a research note on Thursday, April 30th.

Insider Activity

In other news, insider Sanjay K. Shetty acquired 810 shares of Humana stock in a transaction that occurred on Monday, February 23rd. The shares were acquired at an average price of $185.21 per share, with a total value of $150,020.10. Following the completion of the purchase, the insider owned 11,657 shares of the company’s stock, valued at approximately $2,158,992.97. This represents a 7.47% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 0.20% of the company’s stock.

Hedge Funds Weigh In On Humana

Several institutional investors and hedge funds have recently bought and sold shares of HUM. Revolve Wealth Partners LLC acquired a new position in Humana during the fourth quarter worth approximately $202,000. Woodline Partners LP increased its position in Humana by 460.0% during the first quarter. Woodline Partners LP now owns 10,192 shares of the insurance provider’s stock worth $2,697,000 after purchasing an additional 8,372 shares during the last quarter. Sivia Capital Partners LLC increased its position in Humana by 53.7% during the second quarter. Sivia Capital Partners LLC now owns 1,293 shares of the insurance provider’s stock worth $316,000 after purchasing an additional 452 shares during the last quarter. Cresset Asset Management LLC increased its position in Humana by 10.3% during the second quarter. Cresset Asset Management LLC now owns 2,369 shares of the insurance provider’s stock worth $581,000 after purchasing an additional 222 shares during the last quarter. Finally, WINTON GROUP Ltd increased its position in Humana by 58.5% during the second quarter. WINTON GROUP Ltd now owns 2,381 shares of the insurance provider’s stock worth $582,000 after purchasing an additional 879 shares during the last quarter. Institutional investors and hedge funds own 92.38% of the company’s stock.

Humana Stock Up 1.3%

Shares of NYSE HUM opened at $309.85 on Wednesday. Humana has a 12-month low of $163.11 and a 12-month high of $315.35. The company has a market capitalization of $37.20 billion, a PE ratio of 33.14, a price-to-earnings-growth ratio of 2.84 and a beta of 0.68. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.77 and a quick ratio of 1.77. The firm’s 50-day moving average is $210.28 and its two-hundred day moving average is $226.76.

Humana (NYSE:HUM) last announced its quarterly earnings results on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share (EPS) for the quarter, beating the consensus estimate of $9.97 by $0.34. Humana had a net margin of 0.82% and a return on equity of 10.45%. The company had revenue of $39.65 billion for the quarter, compared to the consensus estimate of $39.37 billion. During the same quarter in the prior year, the firm earned $11.58 earnings per share. The company’s revenue for the quarter was up 23.5% compared to the same quarter last year. Humana has set its FY 2026 guidance at 9.000- EPS. Equities analysts anticipate that Humana will post 9 EPS for the current fiscal year.

Humana Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be paid a dividend of $0.885 per share. The ex-dividend date of this dividend is Friday, June 26th. This represents a $3.54 annualized dividend and a dividend yield of 1.1%. Humana’s dividend payout ratio is presently 37.86%.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.